Kaiyue Su

New Highly Potent NLRP3 Inhibitors: Furanochalcone Velutone F Analogues.

Ming-hai Tang, Lijuan Chen, Wenshuang Wu, 2022, ACS medicinal chemistry letters.

Identification of the target protein and molecular mechanism of honokiol in anti-inflammatory action.

Ming-hai Tang, Lijuan Chen, Wenshuang Wu, 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

DNMT3A inhibits E2F1-induced arterial marker expression and impairs angiogenesis in human umbilical artery endothelial cells.

Wenjian Ma, Tongcun Zhang, Y-q Han, 2020, Acta biochimica et biophysica Sinica.

From lead to clinic: A review of the structural design of P2X7R antagonists.

Wenshuang Wu, Ruijia Zhang, Na Li, 2023, European journal of medicinal chemistry.

Discovery of pyrimidine-5-carboxamide derivatives as novel salt-inducible kinases (SIKs) inhibitors for inflammatory bowel disease (IBD) treatment.

Nannan Li, Lijuan Chen, Mingsong Shi, 2023, European journal of medicinal chemistry.

NU6300 covalently reacts with cysteine-191 of gasdermin D to block its cleavage and palmitoylation

Ruijia Zhang, Ming-yang Tang, Min Zhao, 2024, Science advances.

Discovery of Potent, Specific, and Orally Available NLRP3 Inflammasome Inhibitors Based on Pyridazine Scaffolds for the Treatment of Septic Shock and Peritonitis.

Heying Pei, Yong Chen, Ming-yang Tang, 2024, Journal of medicinal chemistry.

Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition.

Ruijia Zhang, Ming-yang Tang, Na Li, 2023, Journal of medicinal chemistry.

Discovery of Triazinone Derivatives as Novel, Specific, and Direct NLRP3 Inflammasome Inhibitors for the Treatment of DSS-Induced Ulcerative Colitis.

Nannan Li, Ruijia Zhang, Ming-yang Tang, 2023, Journal of medicinal chemistry.